Sign in

CIK 0001075880

  • Accelerated filer

KAZIA THERAPEUTICS LTD

Sign in to watch
Ticker
KZIA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
Australia
Entity type
Operating
Phone
+61 298780088
Business address
THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, Australia, 2000
Former names
NOVOGEN LTD
  1. 4 Open-market buy 10% owner bought 9,945 shares at an average $9.14 ($90,914)
  2. 4 Open-market buy 10% owner bought 7,700 shares at $9.63 ($74,119)
  3. 4 Open-market buy 10% owner bought 10,000 shares at $9.23 ($92,256)
  4. 4 Open-market buy 10% owner bought 9,100 shares at an average $9.09 ($82,716)
  5. 4 Open-market buy 10% owner bought 15,200 shares at an average $9.24 ($140,422)
  6. 4 Open-market buy 10% owner bought 8,000 shares at $9.27 ($74,178)
  7. 4 Open-market buy 10% owner bought 18,875 shares at an average $9.54 ($180,021)
  8. 4 Open-market buy 10% owner bought 1,510 shares at $9.98 ($15,070)
  9. 4 Open-market buy 10% owner bought 23,000 shares at $9.93 ($228,328)
  10. 4 Open-market buy 10% owner bought 8,914 shares at $9.97 ($88,873)
  11. 4 Open-market buy 10% owner bought 10,000 shares at an average $9.97 ($99,681)
  12. 4 Open-market buy 10% owner bought 13,000 shares at $9.88 ($128,488)
  13. 4 Open-market buy 10% owner bought 18,202 shares at an average $9.86 ($179,421)
  14. 4 Open-market buy 10% owner bought 1,758 shares at an average $9.64 ($16,950)
  15. 4 Open-market buy 10% owner bought 4,583 shares at an average $9.82 ($45,007)
  16. 4 Open-market buy 10% owner bought 3,300 shares at an average $10.00 ($32,999)
  17. 4 Open-market buy 10% owner bought 6,000 shares at an average $9.92 ($59,534)
  18. 4 Open-market buy 10% owner bought 3,000 shares at $9.99 ($29,970)
  19. 4 Open-market buy 10% owner bought 6,100 shares at $11.30 ($68,930)
  20. 4 Open-market buy Director bought 6,100 shares at $10.42 ($63,561)

Page 3 of 5 · 84 filings